Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market ...